Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.
第一作者:
Roberto,Latagliata
第一单位:
Dipartimento di Biotecnologie Cellulari ed Ematologia, Università, La Sapienza, Via Benevento 6, 00161, Rome, Italy. rob.lati@libero.it
作者:
医学主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);衰老(Aging);抗肿瘤药(Antineoplastic Agents);苯甲酰胺类(Benzamides);队列研究(Cohort Studies);共病现象(Comorbidity);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物监测(Drug Monitoring);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);意大利(Italy);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);男(雄)性(Male);哌嗪类(Piperazines);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis)
DOI
10.1007/s40266-013-0088-6
PMID
23681399
发布时间
2022-04-08
- 浏览29
Drugs & aging
629-37页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



